PMID- 30914174
OWN - NLM
STAT- MEDLINE
DCOM- 20190813
LR  - 20190813
IS  - 1872-8243 (Electronic)
IS  - 1386-5056 (Linking)
VI  - 125
DP  - 2019 May
TI  - Using clinical cancer registry data for estimation of quality indicators: Results 
      from the Norwegian breast cancer registry.
PG  - 102-109
LID - S1386-5056(18)30766-4 [pii]
LID - 10.1016/j.ijmedinf.2019.03.004 [doi]
AB  - INTRODUCTION: Increased focus on quality indicators and the use of clinical 
      registries for breast cancer for real world studies have shown higher compliance 
      to recommended therapy and better survival. In 2010, the European Society of 
      Breast Cancer Specialist (EUSOMA) proposed quality indicators (QI) covering 
      diagnosis, treatment and follow-up. To become a EUSOMA certified Breast Cancer 
      Unit, 14 specified quality indicators, in addition to other requirements, need to 
      be met. To evaluate the compliance and results of recommended treatment in breast 
      cancer care in Norway and to improve the quality of epidemiological data, the 
      Cancer Registry of Norway (CRN) in cooperation with the Norwegian Breast Cancer 
      Group (NBCG) developed the Norwegian Breast Cancer Registry (NBCR). The objective 
      of this study is to assess the feasibility of using the NBCR for estimating the 
      EUSOMA QI individually for all hospitals diagnosing and treating breast cancer in 
      Norway. METHODS: To provide researchers with high quality cancer data as well as 
      for the purpose of national cancer statistics, the CRN employs a cancer registry 
      system to 1) longitudinal capture data from all patients from all medical 
      entities that diagnose and/or treat cancer patients (e.g., pathology, radiology 
      and clinical departments) in Norway; 2) curate data, i.e. validate the 
      correctness of collected data, and assemble the validated cancer data as cancer 
      cases; 3) provide data for analytics and presentation. Estimates for 10 EUSOMA QI 
      were calculated at national and hospital level. To compare hospitals, a summary 
      score of QIs was defined for each hospital. RESULTS: All hospitals currently 
      treating breast cancer patients have the technical ability to submit data to the 
      NBCR for estimation of QIs defined by EUSOMA. Data from pathology and surgery are 
      of high quality. However, data from oncological and radiological departments are 
      incomplete, but improving. This currently hinders three QIs from being 
      calculated. QI on benign to malign diagnosis needs to be calculated at the 
      individual Breast Centre. Over time the adherence to guidelines have improved and 
      the hospital variation for the respective QI have decreased. Two hospitals met 
      all minimum standard on ten QIs in year 2016 and one hospital did not meet one 
      minimum standard, but met all other targets. CONCLUSION: The NBCR has since 2012 
      published annual reports on breast cancer care and for the year 2016 measured 10 
      of 14 QI defined by EUSOMA. Increased compliance of recommended treatment in 
      Norway has been observed during the years the registry has been active.
CI  - Copyright (c) 2019 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Hartmann-Johnsen, Olaf Johan
AU  - Hartmann-Johnsen OJ
AD  - Cancer Registry of Norway, Norway; Department of Breast and Endocrine Surgery, 
      Kalnes Hospital, Norway; University of Oslo, Norway. Electronic address: 
      olafjhj@online.no.
FAU - Karesen, Rolf
AU  - Karesen R
AD  - Cancer Registry of Norway, Norway; University of Oslo, Norway; Oslo University 
      Hospital, Department of Oncology, Norway.
FAU - Schlichting, Ellen
AU  - Schlichting E
AD  - Oslo University Hospital, Department of Oncology, Norway.
FAU - Naume, Bjorn
AU  - Naume B
AD  - University of Oslo, Norway; Oslo University Hospital, Department of Oncology, 
      Norway.
FAU - Nygard, Jan F
AU  - Nygard JF
AD  - Cancer Registry of Norway, Norway.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20190309
PL  - Ireland
TA  - Int J Med Inform
JT  - International journal of medical informatics
JID - 9711057
MH  - Breast Neoplasms/diagnosis/*epidemiology/*therapy
MH  - Female
MH  - Humans
MH  - Norway/epidemiology
MH  - Patient Compliance
MH  - Quality Indicators, Health Care/*standards
MH  - *Registries
OTO - NOTNLM
OT  - Breast cancer
OT  - Cancer registry
OT  - EUSOMA certification
OT  - Quality indicators
EDAT- 2019/03/28 06:00
MHDA- 2019/08/14 06:00
CRDT- 2019/03/28 06:00
PHST- 2018/08/03 00:00 [received]
PHST- 2018/11/03 00:00 [revised]
PHST- 2019/03/06 00:00 [accepted]
PHST- 2019/03/28 06:00 [entrez]
PHST- 2019/03/28 06:00 [pubmed]
PHST- 2019/08/14 06:00 [medline]
AID - S1386-5056(18)30766-4 [pii]
AID - 10.1016/j.ijmedinf.2019.03.004 [doi]
PST - ppublish
SO  - Int J Med Inform. 2019 May;125:102-109. doi: 10.1016/j.ijmedinf.2019.03.004. Epub 
      2019 Mar 9.